NIH Brain Development Cohorts (NBDC) andPopulation Assessment of Tobacco and Health (PATH) StudyBiospecimen Access

The National Institutes of Health, within the Department of Health and Human Services, forecasts this federal discretionary grant opportunity under opportunity number PAR-27-051. The opportunity is titled NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access and is associated with Assistance Listing 93.279, Drug Use and Addiction Research Programs. The National Institute on Drug Abuse seeks to advance its mission by giving the scientific community an opportunity to request access to biospecimens from major longitudinal research studies. The opportunity is currently presented as a forecast rather than a final posted funding announcement. The purpose of the opportunity is to support research using biospecimens from the Adolescent Brain Cognitive Development Study, the HEALthy Brain and Child Development Study, and the Population Assessment of Tobacco and Health Study. Proposed research is expected to be consistent with the objectives of these studies and to maximize the scientific utility of the limited biospecimen samples. Research proposals should expand the knowledge generated through the underlying studies and advance understanding of the multiple genetic and environmental factors, including exposure to substances, that affect health and disease across the life course. The source identifies the funding instrument as a grant and the category of funding activity as Health. It does not provide an estimated total program funding amount, award ceiling, award floor, expected number of awards, detailed allowable cost provisions, project period, indirect cost limitations, or subaward limitations. Accordingly, no specific award amount or spending limit can be established from the forecast. The source expressly states that there is no cost sharing or matching requirement. Grant authorities cited for the forecast include Sections 301 and 405 of the Public Health Service Act, as amended, along with applicable federal regulations. Eligible applicants include state governments, county governments, city or township governments, special district governments, independent school districts, federally recognized Native American tribal governments, other Native American tribal organizations, public housing authorities and Indian housing authorities, public and state controlled institutions of higher education, private institutions of higher education, nonprofits with 501(c)(3) status other than institutions of higher education, and nonprofits without 501(c)(3) status other than institutions of higher education. Additional eligible applicants identified in the source include eligible agencies of the federal government, U.S. territories or possessions, faith-based or community-based organizations, regional organizations, and non-domestic entities or foreign institutions. No individual U.S. state restriction is stated. The forecast does not provide application questions, required proposal components, required attachments, a letter of intent or other pre-application gating requirement, evaluation scoring criteria, or detailed submission mechanics beyond indicating that this is a Grants.gov opportunity. Because these details are absent, applicants should not infer application requirements from the forecast alone. The source language does, however, make clear that proposed research should align with the objectives of the named studies, maximize the scientific utility of limited biospecimens, expand knowledge gained from those studies, and advance understanding of genetic and environmental factors affecting health and disease. The forecast was last updated on August 31, 2026. It lists an estimated post date of May 1, 2026 and an estimated application due date of September 8, 2026. The estimated award date is January 4, 2027, and the estimated project start date is also January 4, 2027, for fiscal year 2027. The source does not state that the opportunity is annual, biennial, quarterly, continuously open, or otherwise recurring, so no recurrence is established. The grantor contact is Heather L. Kimmel, who can be reached at heather.kimmel@nih.gov or 301-443-6504. All dates and requirements remain forecast information and may be updated when the final opportunity is posted.

Align the proposed research with the objectives of the ABCD, HBCD, or PATH studies; demonstrate how the work will maximize the scientific utility of limited biospecimens; expand knowledge gained from the studies; and advance understanding of genetic and environmental factors, including substance exposure, that affect health and disease across the lifetime.